Insight

The latest clinical and preclinical developments in anticancer vaccines – Cell Stress and Immunity Lab

Francisca Borges/Linkedin

Oct 17, 2024, 04:58

The latest clinical and preclinical developments in anticancer vaccines – Cell Stress and Immunity Lab

Cell Stress and Immunity Lab shared on X about a recent paper by Francisca Borges et al. published in OncoImmunology:

“Happy to share our review of the latest clinical and preclinical developments in anticancer vaccines utilizing dendritic cells (DCs). Thanks, Francisca Borges and Raquel Laureano for heavy lifting.”

“Trial watch: anticancer vaccination with dendritic cells”

Authors: Francisca Borges, Raquel Laureano, Isaure Vanmeerbeek, Jenny Sprooten, Octavie Demeulenaere, Jannes Govaerts, Lisa Kinget, Saurabh Saraswat, Stefan Naulaerts and Abhishek Garg et al..

More posts featuring Cell Stress and Immunity Lab on oncodaily.com.

Abhishek Garg anticancer vaccines cancer Cell Stress and Immunity (CSI) Lab csi Francisca Borges Isaure Vanmeerbeek Jannes Govaerts Jenny Sprooten Lisa Kinget Octavie Demeulenaere OncoDaily OncoImmunology Oncology Raquel Laureano Saurabh Saraswat Stefan Naulaerts

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Tedros Adhanom Ghebreyesus: The WHO Academy has opened its door to the world

Special Coverage